Pediatrics Doctors in Mcalester, OK Accepting Medicare

6 Pediatrics doctors found. Showing 1 - 6

Paul Stephen Thomas, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1401 E Van Buren Ave, Mcalester, OK 74501 Phone: 918-426-0240    Fax: 918-423-4051

Johnny Johnston, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1401 E Van Buren Ave, Mcalester, OK 74501 Phone: 918-426-0240    Fax: 918-423-4051

Yan Luo, Pediatrics Medicare: Medicare Enrolled Practice Location: 1401 E Van Buren Ave, Mcalester, OK 74501 Phone: 918-421-8410    Fax: 918-421-8772

Dr. Maila A. Coleman, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1127 S George Nigh Expy, Mcalester, OK 74501 Phone: 918-423-8440    Fax: 918-421-2938

Jody M Wilson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1401 E Van Buren Ave, Mcalester, OK 74501 Phone: 918-421-8410    Fax: 918-421-8772

Dr. Misti K Crawley, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1127 S George Nigh Expy, Mcalester, OK 74501 Phone: 918-423-8440

News Archive

ADVENTRX Pharmaceuticals reports Q2 2009 financials

ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and six months ended June 30, 2009.

Researchers identify genetic risk for type 1 diabetes

A discovery at the Barbara Davis Center for Childhood Diabetes has identified a genetic risk for type 1 diabetes three to four times higher than previously thought possible.

Consent forms for research: Have they improved in 25 years?

The consent forms that people sign before participating in research are widely considered difficult to understand and sometimes inaccurate. The lack of clarity was implicated in a high-profile legal settlement in April between Arizona State University and a Native American tribe, which claimed that blood samples that its members provided for genetic research were used for purposes not stated in the consent form. Efforts have been made to improve the forms, but how effective are they?

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC), a center of excellence to advance and accelerate drug discovery in Singapore, and Debiopharm Group™ (Debiopharm), the Swiss-based global biopharmaceutical company that focuses on the development of prescription drugs that target unmet medical needs including oncology as well as companion diagnostics, today announced the signature of an exclusive research collaboration to develop oral small molecules targeting new class of epigenetic modulators.

Read more Medical News

› Verified 6 days ago